SCHEMBL26116306

SCHEMBL26116306

COc1ccc(CN2CC(C(C)O)C2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.51
▸ MMP1 P03956 1/20 0.50
▸ MMP13 P45452 1/20 0.50
▸ GRM2 Q14416 1/20 0.50
▸ CMA1 P23946 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ PKM P14618 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TACR1 P25103 1/20 0.46
▸ SIRT2 Q8IXJ6 1/20 0.45
▸ SIRT1 Q96EB6 1/20 0.45
▸ GSK3A P49840 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19499093 0.80 SMN1; SMN2 (0.56) GAAMMP1MMP13GRM2CMA1
SCHEMBL2188630 0.80 SMN1; SMN2 (0.56) GAAMMP1MMP13GRM2CMA1
SCHEMBL18603315 0.79 GRM2 (0.62) GAAMMP1MMP13GRM2PKM
SCHEMBL9462348 0.77 GRM2 (0.46) GAAMMP1MMP13GRM2CMA1
SCHEMBL9462353 0.77 GRM2 (0.46) GAAMMP1MMP13GRM2CMA1
SCHEMBL9805556 0.76 GAA (0.43) GAAMMP1MMP13GRM2CMA1
SCHEMBL15958461 0.73 GRM2 (0.52) GAAMMP1MMP13GRM2CMA1
SCHEMBL10277306 0.73 MMP1 (0.58) GAAMMP1MMP13GRM2CMA1
SCHEMBL15400067 0.73 GRM2 (0.52) GAAMMP1MMP13GRM2CMA1
SCHEMBL10277302 0.73 MMP1 (0.58) GAAMMP1MMP13GRM2CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same WASHINGTON UNIVERISTY (US) 2025-09-23 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME DHFR, DHPS, MTHFD1 GAA 733/4885MMP1 2444/4885MMP13 2382/4885
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same DHFR, DHPS, MTHFD1 GAA 733/4885MMP1 2444/4885MMP13 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback